mitoxantrone has been researched along with Sarcoma, Epithelioid in 13 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To establish 2 vaccine-associated feline sarcoma (VAFS) cell lines and to determine their in vitro sensitivity to the chemotherapeutic agents doxorubicin and mitoxantrone." | 7.71 | Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. ( Banerji, N; Kanjilal, S; Kapur, V; Klausner, JS; Williams, LE, 2001) |
| "Mitoxantrone hydrochloride is an anthracenodione that has been reported to be useful when used intracavitary for malignant effusion due to gynaecological malignancies." | 5.29 | Mitoxantrone for malignant pleural effusion due to metastatic sarcoma. ( Holmes, EC; Kelly, J; Rosen, G, 1993) |
| "To establish 2 vaccine-associated feline sarcoma (VAFS) cell lines and to determine their in vitro sensitivity to the chemotherapeutic agents doxorubicin and mitoxantrone." | 3.71 | Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. ( Banerji, N; Kanjilal, S; Kapur, V; Klausner, JS; Williams, LE, 2001) |
| " In the first trial, CDDP dosing was established as 90 mg/m2 with a perfusate time of 90 minutes and temperature of 41 degrees C." | 1.34 | Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. ( Benjamin, RS; Chase, JL; Cormier, JN; Feig, BW; Griffin, JR; Hunt, KK; Lim, SJ; Mansfield, PF; Pisters, PW; Pollock, RE, 2007) |
| "Mitoxantrone hydrochloride is an anthracenodione that has been reported to be useful when used intracavitary for malignant effusion due to gynaecological malignancies." | 1.29 | Mitoxantrone for malignant pleural effusion due to metastatic sarcoma. ( Holmes, EC; Kelly, J; Rosen, G, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spugnini, EP | 1 |
| Fanciulli, M | 1 |
| Citro, G | 1 |
| Baldi, A | 1 |
| Lee, CM | 1 |
| Tannock, IF | 1 |
| Lim, SJ | 1 |
| Cormier, JN | 1 |
| Feig, BW | 1 |
| Mansfield, PF | 1 |
| Benjamin, RS | 1 |
| Griffin, JR | 1 |
| Chase, JL | 1 |
| Pisters, PW | 1 |
| Pollock, RE | 1 |
| Hunt, KK | 1 |
| Presant, CA | 1 |
| Gams, R | 1 |
| Bartolucci, AA | 1 |
| Kelly, J | 1 |
| Holmes, EC | 1 |
| Rosen, G | 2 |
| Eilber, FC | 1 |
| Forscher, C | 1 |
| Nelson, SD | 1 |
| Dorey, F | 1 |
| Eilber, FR | 1 |
| Williams, LE | 1 |
| Banerji, N | 1 |
| Klausner, JS | 1 |
| Kapur, V | 1 |
| Kanjilal, S | 1 |
| Ogilvie, GK | 1 |
| Obradovich, JE | 1 |
| Elmslie, RE | 1 |
| Vail, DM | 1 |
| Moore, AS | 1 |
| Straw, RC | 1 |
| Dickinson, K | 1 |
| Cooper, MF | 1 |
| Withrow, SJ | 1 |
| Kober, F | 1 |
| Heiss, A | 1 |
| Keminger, K | 1 |
| Depisch, D | 1 |
| Young, CW | 1 |
| Raymond, V | 1 |
| Quirt, I | 1 |
| Eisenhauer, E | 1 |
| Bramwell, V | 1 |
| Knowling, M | 1 |
| Grafton, C | 1 |
| Hirte, W | 1 |
| Cripps, M | 1 |
| Maksymiuk, A | 1 |
| Dietel, M | 1 |
| Arps, H | 1 |
| Gerding, D | 1 |
| Trapp, M | 1 |
| Sieck, M | 1 |
| Niendorf, A | 1 |
| Bull, FE | 1 |
| Von Hoff, DD | 1 |
| Balcerzak, SP | 1 |
| Stephens, RL | 1 |
| Panettiere, FJ | 1 |
2 reviews available for mitoxantrone and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Preclinical models in electrochemotherapy: the role of veterinary patients.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma | 2012 |
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival | 1986 |
1 trial available for mitoxantrone and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Topics: Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as T | 1985 |
10 other studies available for mitoxantrone and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration.
Topics: Animals; Antibiotics, Antineoplastic; Antimalarials; Antineoplastic Agents; Breast Neoplasms; Chloro | 2006 |
Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Clinical Tr | 2007 |
Treatment of metastatic sarcomas with mitoxantrone.
Topics: Agranulocytosis; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Drug Evaluation; Female; Hum | 1984 |
Mitoxantrone for malignant pleural effusion due to metastatic sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged | 1993 |
Recurrent gastrointestinal stromal sarcomas.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Gastrointestinal Neoplasms; Humans; Injection | 2000 |
Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Cell Culture Techniques; Doxorubicin; Female; In | 2001 |
Efficacy of mitoxantrone against various neoplasms in dogs.
Topics: Animals; Carcinoma; Dog Diseases; Dogs; Lymphoma; Mitoxantrone; Neoplasms; Prospective Studies; Remi | 1991 |
[Chemotherapy of highly malignant thyroid tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Small Cell; Cisplatin; C | 1990 |
Phase II study of mitoxantrone in untreated and previously minimally treated patients with metastatic soft tissue sarcomas.
Topics: Adult; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Male; Mitoxantrone; Sarcoma | 1987 |
Effectiveness of mitoxantrone on the proliferation of cell cultures derived from malignant mesenchymal tumors of human origin.
Topics: Adolescent; Adult; Aged; Carcinoma; Cell Division; Cisplatin; DNA; Doxorubicin; Humans; Middle Aged; | 1988 |